ITQ PHSA 15220 Nasal Naloxone

The Provincial Health Services Authority (PHSA), acting on its own behalf and as an agent for multiple Regional Health Authorities, in collaboration with the First Nations Health Authority (FNHA), is seeking suppliers to submit quotations for the provision of 4 mg/0.1 mL naloxone hydrochloride nasal spray. This solicitation aims to secure a reliable supply of this critical medication used for emergency treatment of opioid overdoses. The tender titled "ITQ PHSA 15220 Nasal Naloxone" was posted on January 23, 2026, with a submission deadline of February 2, 2026. The contract opportunity is managed under the Federal government structure through the PHSA and invites interested vendors to respond via a formal quotation process. The primary contact for this procurement is Blair MacKinnon, the designated Contracting Authority, who can be reached for inquiries at the provided email address. The solicitation and related documentation are accessible through the Government of Canada’s procurement portal, ensuring transparency and wide access for qualified suppliers. This initiative highlights the coordinated effort between various health authorities to address public health needs by ensuring availability of essential naloxone medication.